{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:36:45Z","timestamp":1793759805182,"version":"4.6.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474467"],"award-info":[{"award-number":["82474467"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.thromres.2025.109450","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:29:58Z","timestamp":1756740598000},"page":"109450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Geographic and diagnostic variations in thrombosis risk among patients with immune thrombocytopenia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"254","author":[{"given":"Yucao","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuecan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109450_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2024.02.005","article-title":"Translating mechanisms into therapeutic strategies for immune thrombocytopenia (ITP): lessons from clinical trials","volume":"235","author":"Delshad","year":"2024","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109450_bb0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12185-016-1974-6","article-title":"Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies","volume":"103","author":"Langeberg","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109450_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.20104","article-title":"Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies","volume":"76","author":"Aledort","year":"2004","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109450_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ejh.12777","article-title":"Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis","volume":"97","author":"Doobaree","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109450_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109109","article-title":"The immune thrombocytopenia paradox: should we be concerned about thrombosis in ITP?","volume":"241","author":"Saldanha","year":"2024","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.thromres.2025.109450_bb0035","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109450_bb0040","first-page":"89","volume":"37","author":"Thrombosis and Hemostasis Group, Hematology sSociety, Chinese Medical Association","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"issue":"8","key":"10.1016\/j.thromres.2025.109450_bb0045","first-page":"617","volume":"41","author":"Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"issue":"9","key":"10.1016\/j.thromres.2025.109450_bb0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.thromres.2025.109450_bb0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2018.10.017","article-title":"Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: an NIS study","volume":"172","author":"Machin","year":"2018","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2025.109450_bb0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/bjh.12318","article-title":"Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies","volume":"161","author":"Kim","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109450_bb0065","first-page":"942","article-title":"The incidence and risk factors for thrombosis in primary immune thrombocytopenia","volume":"39","author":"Huang","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.thromres.2025.109450_bb0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1365-2141.2008.07228.x","article-title":"Antiphospholipid antibodies in adults with immune thrombocytopenic purpura","volume":"142","author":"Pierrot-Deseilligny Despujol","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109450_bb0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/bjh.17709","article-title":"Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study","volume":"195","author":"Lafaurie","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109450_bb0080","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2169\/internalmedicine.55.5536","article-title":"Presence of antiphospholipid antibodies as a risk factor for thrombotic events in patients with connective tissue diseases and idiopathic thrombocytopenic Purpura","volume":"55","author":"Habe","year":"2016","journal-title":"Intern. Med."},{"key":"10.1016\/j.thromres.2025.109450_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.thromres.2022.11.008","article-title":"Risk of thrombosis associated with antiphospholipid antibodies in immune thrombocytopenic purpura: a single center retrospective study of 152 patients","volume":"221","author":"Fayard","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2025.109450_bb0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.thromres.2019.04.016","article-title":"Impact of risk factors on the incidence of arterial thrombosis and venous thromboembolism in adults with primary immune thrombocytopenia - results from two nationwide cohorts","volume":"178","author":"Ekstrand","year":"2019","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2141.2012.09231.x","article-title":"Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study","volume":"159","author":"N\u00f8rgaard","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109450_bb0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3904\/kjim.2011.26.4.449","article-title":"Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia","volume":"26","author":"Yang","year":"2011","journal-title":"Korean J. Intern. Med."},{"issue":"4","key":"10.1016\/j.thromres.2025.109450_bb0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.13787","article-title":"Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study","volume":"174","author":"N\u00f8rgaard","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.thromres.2025.109450_bb0110","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.revmed.2011.07.014","article-title":"Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome","volume":"32","author":"Moulis","year":"2011","journal-title":"Rev. Med. Interne"},{"issue":"8","key":"10.1016\/j.thromres.2025.109450_bb0115","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/jth.12636","article-title":"Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors","volume":"12","author":"Ruggeri","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/00365513.2014.962597","article-title":"Thrombophilia in patients with chronic immune thrombocytopenia","volume":"75","author":"Wong","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.thromres.2025.109450_bb0125","series-title":"Preliminary Clinical Study on Immune Thrombocytopenia Complicated with Arteriovenous Thrombosis[D].SOOCHOW","author":"Tan","year":"2022"},{"issue":"9","key":"10.1016\/j.thromres.2025.109450_bb0130","article-title":"Estimation of risk factors for thrombosis in patients with primary immune thrombocytopenia","volume":"30","author":"Zhang","year":"2017","journal-title":"Journal of Clinical Hematology"},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102342","article-title":"Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes","volume":"8","author":"Goncalves","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109450_bb0140","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.thromres.2025.109450_bb0145","first-page":"603","article-title":"Factors associated with thrombosis in primary immune thrombocytopenia","volume":"25","author":"Yang","year":"2022","journal-title":"Chin. Gen. Pract."},{"issue":"3","key":"10.1016\/j.thromres.2025.109450_bb0150","first-page":"304","article-title":"Clinical analysis of 32 cases with primary immune thrombocytopenic purpura complicating thrombosis","volume":"41","author":"Gu","year":"2022","journal-title":"Journal of Southeast University (Medical Science Edition)"},{"issue":"9","key":"10.1016\/j.thromres.2025.109450_bb0155","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191897","article-title":"Incidence of venous thromboembolism in Korea from 2009 to 2013","volume":"13","author":"Hong","year":"2018","journal-title":"PloS One"},{"issue":"17","key":"10.1016\/j.thromres.2025.109450_bb0165","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1182\/blood-2011-11-393900","article-title":"In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation","volume":"119","author":"Psaila","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2025.109450_bb0170","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.3324\/haematol.2013.087874","article-title":"Patient autoantibodies induce platelet destruction signals via raft-associated glycoprotein Ib\u03b1 and Fc RIIa in immune thrombocytopenia","volume":"98","author":"Urbanus","year":"2013","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.thromres.2025.109450_bb0175","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.thromres.2012.11.021","article-title":"Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura","volume":"131","author":"Sewify","year":"2013","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109450_bb0180","first-page":"158","article-title":"Analysis of genes related to the pathogenesis of chronic primary immune thrombocytopenia","volume":"30","author":"Hao","year":"2024","journal-title":"Chin. J. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0185","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15017644","article-title":"Common genetic risk factors of venous thromboembolism in Western and Asian populations","volume":"15","author":"Huang","year":"2016","journal-title":"Genet. Mol. Res."},{"issue":"19","key":"10.1016\/j.thromres.2025.109450_bb0190","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.110.951236","article-title":"Venous thromboembolism and atherothrombosis: an integrated approach","volume":"121","author":"Piazza","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.thromres.2025.109450_bb0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1076029615585992","article-title":"Fish intake and venous thromboembolism: a systematic literature review","volume":"22","author":"Mattiuzzi","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109450_bb0200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/qjmed\/hci054","article-title":"Castration reduces platelet thromboxane A2 receptor density and aggregability","volume":"98","author":"Ajayi","year":"2005","journal-title":"QJM"},{"issue":"9","key":"10.1016\/j.thromres.2025.109450_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001515","article-title":"Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis","volume":"10","author":"Cheng","year":"2013","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","article-title":"Impacts of cigarette smoking on immune responsiveness: up and down or upside down?","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.thromres.2025.109450_bb0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00277-019-03886-6","article-title":"Evaluation of thrombotic events in patients with immune thrombocytopenia","volume":"99","author":"Ito","year":"2020","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.24234","article-title":"Is ITP a thrombophilic disorder?","volume":"91","author":"Rodeghiero","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109450_bb0230","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2015.11.001","article-title":"Risk of thrombosis in patients with primary immune thrombocytopenia and antiphospholipid antibodies: a systematic review and meta-analysis","volume":"15","author":"Moulis","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"22","key":"10.1016\/j.thromres.2025.109450_bb0235","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1182\/bloodadvances.2019000400","article-title":"Markers of autoimmunity in immune thrombocytopenia: prevalence and prognostic significance","volume":"3","author":"Hollenhorst","year":"2019","journal-title":"Blood Adv."},{"issue":"13","key":"10.1016\/j.thromres.2025.109450_bb0240","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109450_bb0245","doi-asserted-by":"crossref","first-page":"e2023019","DOI":"10.4084\/MJHID.2023.019","article-title":"Nationwide survey on the use of Thrombopoietin receptor agonists (TPO-RA) for the management of Immune Thrombocytopenia in current clinical practice in Italy","volume":"15","author":"Napolitano","year":"2023","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2025.109450_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.revmed.2016.09.016","article-title":"Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study","volume":"38","author":"Weber","year":"2017","journal-title":"Rev. Med. Interne"},{"issue":"3","key":"10.1016\/j.thromres.2025.109450_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/br.2024.1732","article-title":"Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Shen","year":"2024","journal-title":"Biomed Rep."},{"issue":"2","key":"10.1016\/j.thromres.2025.109450_bb0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/09537104.2020.1745168","article-title":"Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review","volume":"32","author":"Birocchi","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2025.109450_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100774","article-title":"Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients","volume":"47","author":"van Dijk","year":"2021","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2025.109450_bb0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2023.01.012","article-title":"Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia","volume":"223","author":"Mehic","year":"2023","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109450_bb0275","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.trsl.2015.09.005","article-title":"Eltrombopag enhances platelet adhesion by upregulating the expression of glycoprotein VI in patients with chronic immune thrombocytopenic purpura","volume":"166","author":"Chiou","year":"2015","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109450_bb0280","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3324\/haematol.2012.075648","article-title":"Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years","volume":"98","author":"Vianelli","year":"2013","journal-title":"Haematologica"},{"issue":"23","key":"10.1016\/j.thromres.2025.109450_bb0285","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1182\/blood-2012-12-467068","article-title":"Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia","volume":"121","author":"Boyle","year":"2013","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.thromres.2025.109450_bb0290","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.2021010735","article-title":"Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia","volume":"138","author":"Palandri","year":"2021","journal-title":"Blood"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:39:22Z","timestamp":1772825962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S0049384825002002"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109450","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geographic and diagnostic variations in thrombosis risk among patients with immune thrombocytopenia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109450"}}